Recombinant Human LMIR2 (C-6His)

Description

EnkiLife provides the Recombinant Human LMIR2 (C-6His) protein,aslo know as CMRF35-Like Molecule 6,CLM-6,CD300 Antigen-Like Family Member C,CMRF35-A1,CMRF-35,Immunoglobulin Superfamily Member 16,IgSF16,CD300c,CD300C,CMRF35,CMRF35A,CMRF35A1,IGSF16, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Leukocyte Mono Ig-like Receptor 2 is produced by our Mammalian expression system and the target gene encoding Gly21-Arg183 is expressed with a 6His tag at the C-terminus.Accession:Q08708. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:18.89 KDa. Background:CD300C is a single-pass type I membrane protein which belongs to the immunoregulatory signaling (IRS) family. CD300C contains one Ig-like V-type domain and is present on the surface of natural killer cells, granulocytes, most myeloid cells, dendritic cells, and a subpopulation of T and B lymphocytes. The CD300C (CMRF-35A) and CD300A (CMRF-35H) molecules are homologous leukocyte surface proteins. CD300a and CD300C play an important role in the cross-regulation of TNF-alpha and IFN-alpha secretion from pDCs. CD300A and CD300C are indistinguishable on the surface of NK cells. The ligand for CD300C is presently unknown.